BridgeBio Oncology Therapeutics, Inc. (BBOT) — Dilution Risk Analysis
Current Snapshot
BridgeBio Oncology Therapeutics, Inc. (BBOT) has a DilutionWatch score of 56/10 and is classified as HIGH risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 56/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
2 shelf registration or ATM offering filings detected in recent history.
Recent filing forms in the source payload: 4 5, SC 13D/A 1, 424B3 2, 3 2.
| Form | Filed | Accession |
|---|---|---|
| 4 | 2026-07-06 | 0001213900-26-075538 |
| SC 13D/A | 2026-07-06 | 0001213900-26-075546 |
| 4 | 2026-07-06 | 0001193125-26-296501 |
| 4 | 2026-07-06 | 0001193125-26-296502 |
| 4 | 2026-07-06 | 0001193125-26-296503 |
| 4 | 2026-07-06 | 0001193125-26-296504 |
| 424B3 | 2026-06-22 | 0001193125-26-277572 |
| 3 | 2026-04-30 | 0001193125-26-197346 |
| 3 | 2026-04-30 | 0001193125-26-197373 |
| 424B3 | 2026-04-29 | 0001193125-26-191533 |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Cash runway | 23 months | Source |
| Three-year share count growth | 14.46% | Source |
DilutionWatch Analysis
- Risk Level
- HIGH (Score: 56/10) Source
- Cash Runway
- 23 months Source
- Share Count Growth (3-Year)
- 14.46% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.